Meta-analyses on the effects of Disease Modifying Anti-Rheumatic Drugs on the most relevant Patient-Reported Outcome domains in Rheumatoid Arthritis.

Marijke van den Dikkenberg Nathalie Luurssen-MasurelTjallingius Martijn KuijperMarc-Redwart KokJohanna Maria Wilhelmina HazesPascal Hendrik Pieter de JongDeirisa Lopes-BarretoAngelique Elisabeth Adriana Maria Weel-Koenders

Published in: Arthritis care & research (2022)

DMARDs decrease the burden in all of the domains that are relevant to patients. Effect sizes may be influenced by DMARD type. Therefore, in the decision for rheumatoid arthritis treatment, patient-reported outcomes should be taken into account.

Keyphrases

patient reported outcomes
rheumatoid arthritis
meta analyses
disease activity
systematic review
end stage renal disease
randomized controlled trial
chronic kidney disease
newly diagnosed
interstitial lung disease
ejection fraction
rheumatoid arthritis patients
prognostic factors